Kamal Raj
Kanpur, Uttar Pradesh, 208002, India
NCT Number: NCT07083778
This prospective randomized controlled trial compared the outcomes of laser versus open surgical techniques in the management of fistula-in-ano among 100 patients at a tertiary care center. Patients were diagnosed with intersphincteric or transsphincteric fistulas using clinical examination and MR fistulogram and were randomly assigned to undergo either laser surgery (n=50) or open surgery (n=50).
The primary endpoints included postoperative pain, hospital stay duration, and time to return to normal activity. Secondary outcomes assessed were recurrence, wound infection, incontinence, need for reoperation, and patient satisfaction.
This study is active but is not currently recruiting participants.
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Kanpur, Uttar Pradesh, 208002, India
This is a prospective, randomized, open-label, parallel-group interventional clinical trial conducted at GSVM Medical College, Kanpur, aimed at comparing the clinical efficacy and safety of laser surgery using the FiLaC (Fistula Laser Closure) technique versus conventional open surgical procedures (fistulotomy or fistulectomy) in the management of fistula-in-ano.
A total of 100 adult patients (>18 years), with a confirmed diagnosis of intersphincteric or transsphincteric fistula-in-ano based on clinical evaluation and magnetic resonance (MR) fistulogram, were enrolled. Following informed consent and screening, patients were randomized in a 1:1 ratio into two arms:
Group A (Laser Surgery Group): Underwent minimally invasive FiLaC procedure using a 1470 nm diode laser and radial fiber probe for endofistular ablation.
Group B (Open Surgery Group): Underwent traditional open surgical procedures including fistulotomy, fistulectomy, or LIFT (Ligation of Intersphincteric Fistula Tract), depending on fistula anatomy.
All surgeries were performed under spinal anesthesia. Postoperative care was standardized across both groups. Patients were followed for a minimum of 3 months with structured clinical assessments at regular intervals.
Primary outcome measures included:
Postoperative pain (VAS score within 7 days)
Duration of hospital stay
Time to resume normal daily activity
Secondary outcomes evaluated were:
Recurrence rate at 3 months
Complete healing within 3 months (closure of both internal and external openings, cessation of discharge)
Anal incontinence rate
Anal stenosis rate
The study intends to assess whether the laser approach offers a meaningful improvement in postoperative morbidity, patient comfort, and quality of life, while also examining risk factors associated with poor surgical outcomes or recurrence.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A minimally invasive procedure using a radial fiber diode laser probe to ablate the fistula tract. Laser energy (10W in pulsed mode) is applied circumferentially as the probe is slowly withdrawn, leading to shrinkage and closure of the fistula tract. The internal opening is closed with absorbable sutures. The procedure is done under spinal or general anesthesia.
Patients in this group will undergo standard open surgical treatment for fistula-in-ano. Based on the type and location of the fistula (intersphincteric or transsphincteric), the surgical procedure may be:
All procedures are performed under spinal anesthesia. The choice of technique is individualized based on MR fistulogram findings and intraoperative assessment. Wounds are managed with regular dressings and allowed to heal by secondary intention. Standard postoperative care includes antibiotics, analgesia, and sitz baths. Follow-up is done at 1 week, 1 month, 3 months, and 6 months.
Time frame: 48 hours post-surgery
Assessment of postoperative pain using the Visual Analogue Scale (VAS) scored from 0 (no pain) to 10 (worst pain imaginable), recorded at 48 hours after surgery.
Time frame: From day of surgery to discharge (typically within 7 days)
Total number of days the patient remains admitted in the hospital from the day of surgery until discharge.
Time frame: Within 6 weeks post-surgery
Number of days taken by the patient to resume normal daily activities or work, as self-reported during follow-up visits.
Time frame: Between 16 to 20 weeks post-surgery
Proportion of patients showing recurrence of fistula-in-ano after surgery, confirmed clinically or radiologically.
Time frame: Within 3 months post-surgery
Number of days from surgery to complete wound healing, defined as epithelialization of the surgical site without discharge.
Time frame: Assessed at each follow-up up to 6 months
Incidence of anal incontinence assessed using the Wexner Incontinence Score, a validated scale ranging from 0 (perfect continence) to 20 (complete incontinence).
Time frame: Within 3 months post-surgery
Proportion of patients developing clinically significant anal stenosis, defined as narrowing of the anal canal requiring intervention or causing obstructive symptoms.
GSVM Medical College
Other
A Randomized Controlled Trial to Determine the Efficacy and Safety of Laser Versus Open Surgery in the Treatment of Fistula-in-Ano at a Tertiary Care Centre
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04187651
Digestive System Diseases, Digestive System Fistula
Uşak, Turkey (Türkiye)
View Trial DetailsNCT07519850
Anal Fissure and Fistula, Anus Diseases
Thessaloniki, Greece
View Trial DetailsNCT07035925
Digestive System Diseases, Digestive System Fistula
Lebanon, New Hampshire, United States
View Trial DetailsNCT05666609
Digestive System Diseases, Digestive System Fistula
Erlangen, Bavaria, Germany
View Trial Details